Trellus Management Company’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

Trellus Management Company’s Portfolio CDAK Stock Details CDAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-64,582	Closed	-$51K	–	71
2022 Q3	$51K	Sell	64,582 -13,945	-18%	-$29.3K	0.06%	53
2022 Q2	$226K	Sell	78,527 -5,506	-7%	-$19.3K	0.28%	46
2022 Q1	$527K	Hold	84,033	–	–	0.31%	35
2021 Q4	$936K	Buy	84,033 +21,063	+33%	+$292K	0.62%	29
2021 Q3	$1.03M	Buy	62,970 +25,170	+67%	+$450K	0.75%	37
2021 Q2	$700K	Sell	37,800 -7,200	-16%	-$138K	0.48%	44
2021 Q1	$679K	Buy	+45,000	New	+$979K	0.35%	43

Other funds holding CDAK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Trellus Management Company's CDAK Position: Q4 2022 in Review

Trellus Management Company sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q4 2022, closing a stake of 64,582 shares — an estimated $51K sold.

Trellus Management Company first reported a position in CDAK in Q1 2021 and held it in 7 quarters. The position peaked at $1.03M in Q3 2021. 40 funds tracked by Wall St. Rank hold CDAK as of Q4 2022.

Trellus Management Company reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Trellus Management Company sold 64,582 Codiak BioSciences, Inc. Common Stock shares in Q4 2022, an estimated $51K.
Trellus Management Company first reported a position in Codiak BioSciences, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Trellus Management Company's Codiak BioSciences, Inc. Common Stock position peaked at $1.03M in Q3 2021.
40 funds tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q4 2022.

Based on Trellus Management Company's 13F filing for Q4 2022, filed 27 Jan 2023.